DIATREME RESOURCES LIMITED — Capital/Financing Update 2009

Sep 28, 2009

==> picture [50 x 58] intentionally omitted <==

DIATREME RESOURCES LIMITED ABN 33 061 267 061

Level 2, 87 Wickham Terrace, Spring Hill, Qld, 4000 PO Box 10288 Brisbane Adelaide Street Queensland 4000

Telephone : 61 7 3832 5666 Facsimile : 61 7 3832 5300 Email : manager@diatreme.com.au Website : www.diatreme.com.au

ASX Code: DRX

Company Announcement Office Australian Securities Exchange Limited

29 September 2009

TRADING HALT (“HALT”) DIATREME RESOURCES LIMITED

Diatreme Resources Limited (“Diatreme”) requested an immediate halt of trading of its securities for the period up to the opening of the market on 29[th] September, 2009. This request was made with the objective of ensuring a proper market in the securities during the period of capital raising.

The company now advises that the capital has been raised with the following results:

21,200,000 shares as subscribed capital $2,597,000 Comprising: 17,900,000 shares $2,192,750 3,300,000 shares subject to approval by shareholders $ 404,250 Subject to EGM – 5,897,959 shares being $722,499.97

• 1,000,000 Shares = $122,500 PLUS

• 4,897,959 Shares = $599,999.97 representing Andrew Tsang (Director)

DRX currently has issued capital of 177,093,250 shares. With the issue of the shares permitted as subscribed capital, the issued capital will become 198,293,250 shares

If the shares which require the approval of shareholders are approved, the shares on issue will become 204,191,209

The placements were carried out by Phillip Capital Australia of Melbourne.

LAWRENCE LITZOW

Corporate Secretary